Status:
COMPLETED
Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors
Lead Sponsor:
University of Miami
Conditions:
Liver Cancer
Hepatic Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective non-blinded case series involving the acquisition of a pair production PET/CT as soon as possible after an already performed Y-90 Sirspheres treatment of hepatic malignancy. It w...
Eligibility Criteria
Inclusion
- Recipient of Selective Internal Radiation Treatment within 5 days.
- Anticipated ability to remain still for up to 40 minutes
Exclusion
- Anticipated Inability to lie still for up to 40 minutes
- Severe claustrophobia
- Significant cardiovascular instability, or instability of other medical/surgical conditions, such that it would be deemed unsafe or technically not feasible to obtain a PET/CT, as determined by the any member of the investigative team
- Failed deployment of the planned Y-90 treatment for any reason
- Duration of time longer than 5 days since administration of the Y-90 treatment
- Age \<18
- Known pregnancy
Key Trial Info
Start Date :
April 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT02202317
Start Date
April 1 2013
End Date
October 1 2016
Last Update
December 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jackson Health System
Miami, Florida, United States, 33136